nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.0856	0.0954	CcSEcCtD
Terlipressin—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.0768	0.0856	CcSEcCtD
Terlipressin—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.071	0.0792	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.0602	0.0671	CcSEcCtD
Terlipressin—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.0554	0.0617	CcSEcCtD
Terlipressin—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.0484	0.054	CcSEcCtD
Terlipressin—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0417	0.0464	CcSEcCtD
Terlipressin—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0404	0.0451	CcSEcCtD
Terlipressin—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0396	0.0442	CcSEcCtD
Terlipressin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.03	0.0334	CcSEcCtD
Terlipressin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0298	0.0332	CcSEcCtD
Terlipressin—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.0278	0.031	CcSEcCtD
Terlipressin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.0253	0.0283	CcSEcCtD
Terlipressin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0248	0.0276	CcSEcCtD
Terlipressin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.0238	0.0265	CcSEcCtD
Terlipressin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0205	0.0229	CcSEcCtD
Terlipressin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.0202	0.0226	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0201	0.0224	CcSEcCtD
Terlipressin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.019	0.0212	CcSEcCtD
Terlipressin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0189	0.0211	CcSEcCtD
Terlipressin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0188	0.021	CcSEcCtD
Terlipressin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0173	0.0193	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0167	0.0187	CcSEcCtD
Terlipressin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0171	CcSEcCtD
Terlipressin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0148	CcSEcCtD
Terlipressin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.0123	0.0138	CcSEcCtD
Terlipressin—Headache—Riluzole—amyotrophic lateral sclerosis	0.0122	0.0135	CcSEcCtD
Terlipressin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0128	CcSEcCtD
Terlipressin—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—AQP4—amyotrophic lateral sclerosis	0.00932	0.0906	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.00877	0.0852	CbGpPWpGaD
Terlipressin—AVPR2—Aquaporin-mediated transport—AQP4—amyotrophic lateral sclerosis	0.00813	0.079	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.00608	0.0591	CbGpPWpGaD
Terlipressin—AVPR2—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.00604	0.0587	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.00413	0.0401	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.00286	0.0278	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.00284	0.0276	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00277	0.0269	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00211	0.0205	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00205	0.0199	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00192	0.0186	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.0019	0.0185	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.0018	0.0175	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00146	0.0142	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00145	0.0141	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00132	0.0128	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.00125	0.0121	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.00124	0.012	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00121	0.0117	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00119	0.0116	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00112	0.0109	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00112	0.0109	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00108	0.0105	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.001	0.00972	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00092	0.00894	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000843	0.00819	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000838	0.00814	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000832	0.00808	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000826	0.00802	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00082	0.00796	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000793	0.0077	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000752	0.0073	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00075	0.00728	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000744	0.00723	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000728	0.00707	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000646	0.00628	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000639	0.00621	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000638	0.0062	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000633	0.00615	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000584	0.00568	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00058	0.00564	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00055	0.00534	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000546	0.0053	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000534	0.00519	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000521	0.00506	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00052	0.00505	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000517	0.00502	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000505	0.0049	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000501	0.00487	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000472	0.00459	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000448	0.00435	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000445	0.00432	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000443	0.0043	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00044	0.00427	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000439	0.00427	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000412	0.004	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000392	0.00381	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.00037	0.0036	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000368	0.00357	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.00036	0.0035	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000358	0.00348	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000336	0.00326	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000327	0.00318	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000325	0.00316	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000316	0.00307	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000304	0.00296	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000302	0.00294	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000285	0.00277	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000283	0.00275	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000279	0.00271	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000272	0.00264	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00027	0.00262	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.00026	0.00252	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000233	0.00226	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000231	0.00224	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000219	0.00213	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000217	0.00211	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000215	0.00208	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000193	0.00188	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000192	0.00186	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.00018	0.00175	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000179	0.00174	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000165	0.0016	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000156	0.00152	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000149	0.00144	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000148	0.00143	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.00014	0.00136	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000114	0.00111	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000114	0.0011	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000108	0.00105	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000107	0.00104	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000106	0.00103	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.72e-05	0.000944	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.65e-05	0.000937	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.34e-05	0.000713	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.29e-05	0.000708	CbGpPWpGaD
